Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Nath Bio-Genes (India) Ltd

NATHBIOGEN
NSE
196.01
8.42%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Nath Bio-Genes (India) Ltd

NATHBIOGEN
NSE
196.01
8.42%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
373Cr
Close
Close Price
196.01
Industry
Industry
Floriculture/Tissue Culture
PE
Price To Earnings
8.39
PS
Price To Sales
0.84
Revenue
Revenue
445Cr
Rev Gr TTM
Revenue Growth TTM
25.14%
PAT Gr TTM
PAT Growth TTM
13.72%
Peer Comparison
How does NATHBIOGEN stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
NATHBIOGEN
VS

Quarterly Results

Upcoming Results on
4 May 2026
Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
452352332432443237522844466
Growth YoY
Revenue Growth YoY%
65.312.43.925.4-4.33.742.616.220.816.336.278.9
Expenses
ExpensesCr
411981826392072729522453862
Operating Profit
Operating ProfitCr
437564375803864
OPM
OPM%
8.815.722.117.89.115.015.021.80.813.513.95.4
Other Income
Other IncomeCr
000000004244
Interest Expense
Interest ExpenseCr
232312341345
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
234222341423652
Tax
TaxCr
000110011111
PAT
PATCr
133243331313752
Growth YoY
PAT Growth YoY%
101.28.62.0183.081.9-0.1-26.0-30.6-43.511.8334.2-39.6
NPM
NPM%
3.214.26.712.06.113.73.57.22.913.111.02.4
EPS
EPS
0.817.60.92.01.917.50.51.30.419.62.50.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
124138278301333365445
Growth
Revenue Growth%
11.18.310.49.722.1
Expenses
ExpensesCr
108118241253283315397
Operating Profit
Operating ProfitCr
16203749505048
OPM
OPM%
13.014.413.416.215.013.710.9
Other Income
Other IncomeCr
11-8714514
Interest Expense
Interest ExpenseCr
24111091013
Depreciation
DepreciationCr
5533344
PBT
PBTCr
912-6336424145
Tax
TaxCr
0141223
PAT
PATCr
912-6735403945
Growth
PAT Growth%
27.7152.013.2-2.617.1
NPM
NPM%
7.48.5-24.211.611.910.610.1
EPS
EPS
5.87.3-35.518.421.320.123.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
16161919191919
Reserves
ReservesCr
3041523554591625661
Current Liabilities
Current LiabilitiesCr
7298194216262365317
Non Current Liabilities
Non Current LiabilitiesCr
233381718
Total Liabilities
Total LiabilitiesCr
1201587397938801,0261,014
Current Assets
Current AssetsCr
96120468521572690706
Non Current Assets
Non Current AssetsCr
2439272272309336308
Total Assets
Total AssetsCr
1201587397938801,0261,014

Cash Flow

Consolidated
Standalone
Financial YearMar 2013Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1417387518
Investing Cash Flow
Investing Cash FlowCr
-21-20-3-27-4
Financing Cash Flow
Financing Cash FlowCr
6-22-2-8-2
Net Cash Flow
Net Cash FlowCr
-1-25343911
Free Cash Flow
Free Cash FlowCr
-716364810
CFO To PAT
CFO To PAT%
121.0-25.3109.6188.345.5
CFO To EBITDA
CFO To EBITDA%
71.445.878.7149.635.3

Ratios

Consolidated
Standalone
Financial YearMar 2012Mar 2013Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
00405269330277
Price To Earnings
Price To Earnings
0.00.00.07.78.37.2
Price To Sales
Price To Sales
0.00.01.50.91.00.8
Price To Book
Price To Book
0.00.00.80.50.50.4
EV To EBITDA
EV To EBITDA
0.30.813.36.97.36.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
96.9101.496.994.3102.7124.7
OPM
OPM%
13.014.413.416.215.013.7
NPM
NPM%
7.48.5-24.211.611.910.6
ROCE
ROCE%
19.921.1-8.36.87.06.7
ROE
ROE%
20.120.4-12.46.16.56.0
ROA
ROA%
7.77.4-9.14.44.53.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Company Profile** Nath Bio-Genes (India) Ltd (NBIL) is a leading Indian seed technology company with over three decades of experience in agricultural innovation. Specializing in hybrid and genetically modified (GM) seeds, the company serves as a key enabler of India’s transition toward high-yield, climate-resilient, and sustainable agriculture. With a science-led approach, NBIL develops genetically pure, premium-quality seeds and integrated farm productivity solutions for field crops, vegetables, and plant nutrition. The company is publicly listed and operates as a pan-India, multi-crop, and multi-product organization, with strategic international operations underway. --- ### **Core Business & Product Portfolio** NBIL operates in three primary verticals: 1. **Hybrid and GM Seeds** – For cotton, hybrid paddy, maize, bajra (pearl millet), wheat, mustard, and vegetable crops (tomato, okra, chili, cucumber, etc.). 2. **Plant Nutrition Solutions (PNS)** – High-margin products such as **Win-Chi-Win**, soil conditioners (e.g., Windrow GOLii, Winhall Granules), and biotonic supplements (e.g., WINPro GOLii, WINall Granules). 3. **Integrated Seed Technology & Agronomic Support** – Farmer education, crop demonstrations, and extension programs. **Flagship Products**: - **Cotton**: *Sanket*, *Nath Jumbo*, *RANA* – top-ranked in ICAR trials, with 200–250 bolls per plant (vs. 130–150 for competitors). - **Paddy**: *Loknath*, *Gorakhnath*, *Dhadak*, *Dhadak Gold* – developed for early maturity, fine grain quality, and resistance to Bacterial Leaf Blight (BLB) and Brown Planthopper (BPH). - **Vegetables**: *Tomato Akhand* (virus-resistant, all-season hybrid), *Super-27 Bajra*, and *Hybrid Chili Rana*. - **Plant Nutrition**: *Win-Chi-Win* – foliar spray with 70%+ gross margins. --- ### **Research & Development (R&D)** - **DSIR-Recognized Innovation Centers**: Supported by a team of experienced scientists, plant breeders, and biotechnologists. - **R&D Investment**: INR 10–12 crores annually (4–5% of revenue), with a 7–10 year innovation cycle. - **R&D Infrastructure**: - 40+ breeding and evaluation stations across 325 acres in diverse agro-climatic zones. - Proprietary germplasm collection with trait-specific resistance to pests, diseases, drought, and heat. - Focus on molecular marker-assisted breeding (e.g., DNA tech for rice and tomato) alongside conventional methods. - **Collaborations**: Partners with global institutions – NRCPB, ICRISAT, CIMMYT, IRRI. - **Innovation Pipeline**: - Next-gen cotton hybrids with pink bollworm and sucking pest resistance, medium-to-large boll size, and wide adaptability. - Heat-tolerant tomato variety (*North Akhand*) capable of growth at 47°C. - Disease-resistant okra and tomato with dual resistance markers. --- ### **Production & Infrastructure** - **Seed Production**: - Over 30,000 acres under contracted cultivation with 25,000+ growers. - 10 processing plants, 17 branch offices across 23 Indian states. - Key facilities in **Chhatrapati Sambhajinagar (Maharashtra)** and **Munipalli, Nizamabad (Telangana)**. - **Storage & Logistics**: - 25,000 MT capacity in cold storage, conditioning godowns, and warehouses. - Asset-light model with long-term leases for operational efficiency. - **Quality Control**: - Over **200,000 annual seed quality tests** for genetic purity, germination, and compliance. - Adheres to national traceability and certification standards (e.g., ICAR, state seed boards). --- ### **Market Performance & Growth Drivers (as of Nov 2025)** - **Cotton Seeds**: - H1 FY26 volume: **1.11 million packets** (+6% YoY), value up **26.3%** due to premium hybrids. - Flagship brands *Sanket* and *Jumbo* dominate with high farmer retention and yield superiority. - Despite illegal RRF BT seed presence, NBIL remains resilient due to product performance. - **Paddy**: - Stable base revenue; strategic shift toward **high-margin hybrid paddy**. - *Dhadak* and *Dhadak Gold* show strong market traction. - **Maize**: - Double-digit growth in FY25 due to favorable agro-climatic conditions and hybrid adoption. - **Vegetable Seeds**: - **Fastest-growing segment** – 60% value growth in FY25. - *Akhand Tomato* and *Super-27 Bajra* are key success stories. - Pipeline includes virus-resistant okra and improved gourd varieties. - **Plant Nutrition Solutions (PNS)**: - Sustained double-digit growth; **Win-Chi-Win sales up 34% in FY24**. - Expansion into bio-organic additives to support soil health. --- ### **Diversification & Strategic Focus** NBIL is executing **Strategy 4.0** to de-risk its business and build long-term resilience: 1. **Reduce Crop Concentration**: - Target to limit any single crop’s revenue share to **<25%**. - Cotton and paddy previously accounted for ~59% (down from 65% in past). 2. **Non-Cotton, Non-Paddy (NCP) Growth**: - NCP segment reached **48% of total revenue (INR 171 crores)** in FY25, up from 43%. - Maize (+47%), Bajra (+66%), Wheat (+36% value), and Mustard are core growth drivers. 3. **Operational Efficiency**: - Debtor days reduced from 120–130 to **88 days** in 3–4 years. - Focus on working capital optimization and inventory management. 4. **R&D-Led Differentiation**: - Prioritizing high-margin, patented hybrids with superior performance and resistance. --- ### **Geographic Expansion & International Ventures** - **Uzbekistan (Flagship JV)**: - **Nath Bio-Genes (Central Asia) LLC**, 90% owned, based in Samarkand. - 600-hectare cotton production in first full year; contribution-level break-even achieved. - Government-backed land and infrastructure; future plans for proprietary BT cotton launch. - **Philippines**: - BT gene approved; hybrids demonstrated successfully. - Preparing for **commercial sales to government agencies** in upcoming season. - **Africa**: - Active trials in Sudan, Egypt, and Myanmar. - Expansion delayed in some regions due to geopolitical instability. - **Global Strategy**: - Assessing markets in Africa, Southeast Asia, and the Middle East. - Focus on geographies with climatic similarity to India. - Export presence in Bangladesh, Egypt, Myanmar. --- ### **Distribution & Farmer Engagement** - **Domestic Network**: - **20,000+ distributors and dealers** across 131 regions in 23 states. - 400+ **Nath Farm Advisors (NFAs)** providing on-ground support. - Farmer education programs, crop demonstrations, and seasonal training. - **Feedback Loop**: - Customizes products based on **farmer needs and agro-climatic data**. - Crop patterns: Kharif (cotton, maize, paddy); Rabi (wheat, mustard, vegetables). - **Direct-to-Farmer Initiatives**: - Exploring direct retail expansion to reach 20,000+ retail outlets. - Urban gardening focus in metro areas like Mumbai. --- ### **Key Competitive Advantages** - **Product Superiority**: Industry-leading cotton hybrids with **200–250 bolls per plant**, disease resistance, and low input costs. - **R&D Scale**: Proprietary germplasm, long-term partnerships, and global R&D recognition. - **Market Intelligence**: Deep understanding of regional agronomy and cropping cycles. - **Integrated Model**: Seed + nutrient + advisory = holistic farm productivity solution. - **Brand Trust**: Sanket and Jumbo are **top 3 in ICAR trials**; strong farmer loyalty.